Regulation and Function of the atypical cadherin FAT1 in hepatocellular carcinoma

[1]  R. Thorne,et al.  Sleeping Giants: Emerging Roles for the Fat Cadherins in Health and Disease , 2014, Medicinal research reviews.

[2]  C. Sarkar,et al.  FAT1 acts as an upstream regulator of oncogenic and inflammatory pathways, via PDCD4, in glioma cells , 2013, Oncogene.

[3]  M. Katoh,et al.  Function and cancer genomics of FAT family genes , 2012, International journal of oncology.

[4]  C. Hellerbrand,et al.  Hop bitter acids inhibit tumorigenicity of hepatocellular carcinoma cells in vitro. , 2012, Oncology reports.

[5]  A. Bosserhoff,et al.  Expression and function of the atypical cadherin FAT1 in chronic liver disease. , 2012, Biochemical and biophysical research communications.

[6]  G. Colditz,et al.  Differentially expressed genes regulating the progression of ductal carcinoma in situ to invasive breast cancer. , 2012, Cancer research.

[7]  R. Thorne,et al.  The Fat1 cadherin is overexpressed and an independent prognostic factor for survival in paired diagnosis–relapse samples of precursor B-cell acute lymphoblastic leukemia , 2012, Leukemia.

[8]  Jianguo Wu,et al.  Hypoxia Induces Genomic DNA Demethylation through the Activation of HIF-1α and Transcriptional Upregulation of MAT2A in Hepatoma Cells , 2011, Molecular Cancer Therapeutics.

[9]  A. Zhu,et al.  The role of signaling pathways in the development and treatment of hepatocellular carcinoma , 2010, Oncogene.

[10]  O. Rosmorduc,et al.  Hypoxia: a link between fibrogenesis, angiogenesis, and carcinogenesis in liver disease. , 2010, Seminars in liver disease.

[11]  C. Hellerbrand,et al.  Xanthohumol, a chalcon derived from hops, inhibits hepatic inflammation and fibrosis. , 2010, Molecular nutrition & food research.

[12]  G. Berx,et al.  Involvement of members of the cadherin superfamily in cancer. , 2009, Cold Spring Harbor perspectives in biology.

[13]  A. Bosserhoff,et al.  Bone morphogenetic protein 4 is induced in hepatocellular carcinoma by hypoxia and promotes tumour progression , 2009, The Journal of pathology.

[14]  W. Gedroyc,et al.  Hepatocellular carcinoma: current trends in worldwide epidemiology, risk factors, diagnosis and therapeutics , 2009, Expert review of gastroenterology & hepatology.

[15]  C. Qin,et al.  Programmed cell death 4 (PDCD4) suppresses metastastic potential of human hepatocellular carcinoma cells , 2009, Journal of experimental & clinical cancer research : CR.

[16]  A. Bosserhoff,et al.  Activated hepatic stellate cells promote tumorigenicity of hepatocellular carcinoma , 2009, Cancer science.

[17]  C. Sarkar,et al.  Frequent loss of heterozygosity and altered expression of the candidate tumor suppressor gene 'FAT' in human astrocytic tumors , 2009, BMC Cancer.

[18]  Shelly C. Lu,et al.  S‐Adenosylmethionine in cell growth, apoptosis and liver cancer , 2008, Journal of gastroenterology and hepatology.

[19]  A. Bosserhoff,et al.  The novel gene MIA2 acts as a tumour suppressor in hepatocellular carcinoma , 2007, Gut.

[20]  T. Miki,et al.  Identification of homozygous deletions of tumor suppressor gene FAT in oral cancer using CGH-array , 2007, Oncogene.

[21]  M. Kretzler,et al.  Differentially Spliced Isoforms of FAT1 Are Asymmetrically Distributed within Migrating Cells* , 2007, Journal of Biological Chemistry.

[22]  K. Bertrand,et al.  Induction of DNA Hypomethylation by Tumor Hypoxia , 2007, Epigenetics.

[23]  X. Coumoul,et al.  RNAi-based conditional gene knockdown in mice using a U6 promoter driven vector , 2007, International journal of biological sciences.

[24]  W. Nelson,et al.  Cadherins in development: cell adhesion, sorting, and tissue morphogenesis. , 2006, Genes & development.

[25]  H. Zhang,et al.  Involvement of programmed cell death 4 in transforming growth factor-β1-induced apoptosis in human hepatocellular carcinoma , 2006, Oncogene.

[26]  N. Sibinga,et al.  The Fat1 cadherin integrates vascular smooth muscle cell growth and migration signals , 2006, The Journal of cell biology.

[27]  A. Leong,et al.  Immunohistological localisation of human FAT1 (hFAT) protein in 326 breast cancers. Does this adhesion molecule have a role in pathogenesis? , 2006, Pathology.

[28]  C. Hellerbrand,et al.  PD-L1 is induced in hepatocytes by viral infection and by interferon-α and -γ and mediates T cell apoptosis , 2006 .

[29]  A. Leong,et al.  FAT, E-cadherin, β catenin, HER 2/neu, Ki67 immunoexpression, and histological grade in intrahepatic cholangiocarcinoma , 2005, Journal of Clinical Pathology.

[30]  M. Takeichi,et al.  New insights into Fat cadherins , 2005, Journal of Cell Science.

[31]  A. Bosserhoff,et al.  In situ expression patterns of melanoma inhibitory activity 2 in healthy and diseased livers , 2005, Liver international : official journal of the International Association for the Study of the Liver.

[32]  L. Holzman,et al.  Protocadherin FAT1 binds Ena/VASP proteins and is necessary for actin dynamics and cell polarization , 2004, The EMBO journal.

[33]  Giulio Gabbiani,et al.  The stroma reaction myofibroblast: a key player in the control of tumor cell behavior. , 2004, The International journal of developmental biology.

[34]  V. Erdmann,et al.  Differentiating the functional role of hypoxia‐inducible factor (HIF)‐1α and HIF‐2α (EPAS‐1) by the use of RNA interference: erythropoietin is a HIF‐2α target gene in Hep3B and Kelly cells , 2004 .

[35]  S. Blair,et al.  Interactions between Fat and Dachsous and the regulation of planar cell polarity in the Drosophila wing , 2004, Development.

[36]  C. ffrench-Constant,et al.  Mice Lacking the Giant Protocadherin mFAT1 Exhibit Renal Slit Junction Abnormalities and a Partially Penetrant Cyclopia and Anophthalmia Phenotype , 2003, Molecular and Cellular Biology.

[37]  Thomas S Weiss,et al.  Cellular damage to human hepatocytes through repeated application of 5-aminolevulinic acid. , 2003, Journal of hepatology.

[38]  E. Wagner,et al.  Liver Tumor Development c-Jun Antagonizes the Proapoptotic Activity of p53 , 2003, Cell.

[39]  Ping Liu,et al.  Activation of NF-kappaB, AP-1 and STAT transcription factors is a frequent and early event in human hepatocellular carcinomas , 2002 .

[40]  L. Tacchini,et al.  Hepatocyte growth factor signalling stimulates hypoxia inducible factor-1 (HIF-1) activity in HepG2 hepatoma cells. , 2001, Carcinogenesis.

[41]  S. Lepreux,et al.  Expression and cellular localization of fibrillin-1 in normal and pathological human liver. , 2001, Journal of hepatology.

[42]  B. le Bail,et al.  Osteonectin/SPARC is overexpressed in human hepatocellular carcinoma , 1999, The Journal of pathology.

[43]  B. le Bail,et al.  Myofibroblasts are responsible for collagen synthesis in the stroma of human hepatocellular carcinoma: an in vivo and in vitro study. , 1999, Journal of hepatology.

[44]  J. Hwang,et al.  Changes in S‐adenosylmethionine synthetase in human liver cancer: Molecular characterization and significance , 1996, Hepatology.

[45]  R. Poulsom,et al.  Molecular cloning and tissue expression of FAT, the human homologue of the Drosophila fat gene that is located on chromosome 4q34-q35 and encodes a putative adhesion molecule. , 1995, Genomics.

[46]  M. Vázquez‐Chantada,et al.  SAMe and HuR in liver physiology: usefulness of stem cells in hepatic differentiation research. , 2012, Methods in molecular biology.

[47]  P. Oefner,et al.  Gastrointestinal , Hepatobiliary , and Pancreatic Pathology Down-Regulation of Methylthioadenosine Phosphorylase ( MTAP ) Induces Progression of Hepatocellular Carcinoma via Accumulation of 5 =-Deoxy-5 =-Methylthioadenosine ( MTA ) , 2011 .

[48]  P. Oefner,et al.  Tumorigenesis and Neoplastic Progression Reduced Expression of Fibroblast Growth Factor Receptor 2 IIIb in Hepatocellular Carcinoma Induces a More Aggressive Growth , 2010 .

[49]  Geng-wen Huang,et al.  Expression of hypoxia-inducible factor 1alpha and vascular endothelial growth factor in hepatocellular carcinoma: Impact on neovascularization and survival. , 2005, World journal of gastroenterology.

[50]  Peter-Tobias Stoll,et al.  Charitable State-Controlled Foundation Human Tissue and Cell Research: Ethic and Legal Aspects in the Supply of Surgically Removed Human Tissue For Research in the Academic and Commercial Sector in Germany , 2004, Cell and Tissue Banking.

[51]  Tumorigenesis and Neoplastic Progression GLUT1 Expression Is Increased in Hepatocellular Carcinoma and Promotes Tumorigenesis , 2022 .